Related Experiment Video
Updated: Jun 16, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Kikuchi-Fujimoto disease
Charles Blake Hutchinson1, Endi Wang
1Department of Pathology, Duke University Medical Center, 1 Trent Dr, Box 3712, Durham, NC 27710, USA. blake.hutchinson@duke.edu
Kikuchi-Fujimoto disease, a benign lymphadenopathy, presents with fever and systemic symptoms. Diagnosis requires histopathology, excluding lymphoma and lupus, with spontaneous resolution typical.
Area of Science:
- Pathology
- Immunology
- Oncology
Background:
- Kikuchi-Fujimoto disease (KFD), or histiocytic necrotizing lymphadenitis, is a rare, self-limiting condition.
- It typically affects young adults of Asian descent, presenting with lymphadenopathy, fever, and systemic symptoms.
Purpose of the Study:
- To summarize the key features, diagnostic criteria, and management of Kikuchi-Fujimoto disease.
- To highlight the importance of differentiating KFD from other conditions with similar presentations.
Main Methods:
- Review of histopathologic findings in involved lymph nodes.
- Clinical and laboratory data analysis.
- Differential diagnosis considerations including Non-Hodgkin lymphoma and Systemic Lupus Erythematosus.
Main Results:
- KFD is characterized by lymph node necrosis, histiocyte proliferation, and specific immune cell infiltration (plasmacytoid dendritic cells, CD8+ T cells).
- Diagnosis relies on histopathology and exclusion of other diseases; no specific lab tests exist.
- The disease typically resolves spontaneously within four months with supportive care.
Conclusions:
- Kikuchi-Fujimoto disease is a distinct clinicopathologic entity requiring careful diagnosis through exclusion.
- Distinguishing KFD from Non-Hodgkin lymphoma and Systemic Lupus Erythematosus is crucial due to differing treatment strategies.
- Supportive management is the mainstay of treatment, leading to self-limited disease course.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations
